82 related articles for article (PubMed ID: 23479080)
21. Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors.
Unterberger EB; Eichner J; Wrzodek C; Lempiäinen H; Luisier R; Terranova R; Metzger U; Plummer S; Knorpp T; Braeuning A; Moggs J; Templin MF; Honndorf V; Piotto M; Zell A; Schwarz M
Int J Cancer; 2014 Oct; 135(7):1574-85. PubMed ID: 24535843
[TBL] [Abstract][Full Text] [Related]
22. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Altug-Teber O; Riess O; Bonin M; Jobst J; Kaiser S; Buchmann A; Schwarz M
Hepatology; 2005 Aug; 42(2):353-61. PubMed ID: 15965925
[TBL] [Abstract][Full Text] [Related]
23. [Characteristics of hepatocarcinogenesis after single exposure of synchronized cells of the regenerating liver to N-nitrosodiethylamine and subsequent administration of phenobarbital].
Osipova LA; Vinarchuk MP; Khranovskaia LN; Bykorez AI
Eksp Onkol; 1987; 9(5):61-4. PubMed ID: 3691396
[TBL] [Abstract][Full Text] [Related]
24. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis of vanadium-mediated inhibition of hepatocellular preneoplasia during experimental hepatocarcinogenesis in rats.
Chakraborty T; Swamy AH; Chatterjee A; Rana B; Shyamsundar A; Chatterjee M
J Cell Biochem; 2007 May; 101(1):244-58. PubMed ID: 17243116
[TBL] [Abstract][Full Text] [Related]
26. High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.
Mattu S; Saliba C; Sulas P; Zavattari P; Perra A; Kowalik MA; Monga SP; Columbano A
Am J Pathol; 2018 Nov; 188(11):2497-2507. PubMed ID: 30201494
[TBL] [Abstract][Full Text] [Related]
27. Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines.
Neuwelt AJ; Wu YJ; Knap N; Losin M; Neuwelt EA; Pagel MA; Warmann S; Fuchs J; Czauderna P; Wozniak M
Neoplasia; 2009 Oct; 11(10):1003-11. PubMed ID: 19794959
[TBL] [Abstract][Full Text] [Related]
28. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
Bull RJ; Sasser LB; Lei XC
Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
[TBL] [Abstract][Full Text] [Related]
29. [Ratio of low- and high-spin cytochrome P-450 in liver microsomes of N-nitrosodiethylamine-induced hepatomas].
Mel'nykov OR; Momot VIa; P'iatchanina TV; Sydoryk IeP
Fiziol Zh (1994); 2005; 51(5):85-9. PubMed ID: 16329398
[TBL] [Abstract][Full Text] [Related]
30. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
[TBL] [Abstract][Full Text] [Related]
31. β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice.
Kuwata K; Inoue K; Ichimura R; Takahashi M; Kodama Y; Shibutani M; Yoshida M
Toxicol Pathol; 2017 Jun; 45(4):493-505. PubMed ID: 28580885
[TBL] [Abstract][Full Text] [Related]
32. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
33. Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras.
Braeuning A; Schwarz M
Biol Chem; 2010 Nov; 391(11):1305-13. PubMed ID: 20707599
[TBL] [Abstract][Full Text] [Related]
34. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity.
Cheung C; Yu AM; Ward JM; Krausz KW; Akiyama TE; Feigenbaum L; Gonzalez FJ
Drug Metab Dispos; 2005 Mar; 33(3):449-57. PubMed ID: 15576447
[TBL] [Abstract][Full Text] [Related]
35. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
[TBL] [Abstract][Full Text] [Related]
36. [Increase of general toxic effects and decrease of hepatocarcinogenic effects of diethylnitrosamine administered to mice in conjunction with isopropanol].
Kaledin VI; Baginskaia NV; Vasiunina EA; Il'nitskaia SI; Ovchinnikova LP
Vopr Onkol; 2012; 58(5):658-62. PubMed ID: 23600284
[TBL] [Abstract][Full Text] [Related]
37. Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis.
Braeuning A; Jaworski M; Schwarz M; Köhle C
Toxicology; 2006 Oct; 227(1-2):127-35. PubMed ID: 16959394
[TBL] [Abstract][Full Text] [Related]
38. miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression.
Chowdhary V; Teng KY; Thakral S; Zhang B; Lin CH; Wani N; Bruschweiler-Li L; Zhang X; James L; Yang D; Junge N; Brüschweiler R; Lee WM; Ghoshal K
Am J Pathol; 2017 Dec; 187(12):2758-2774. PubMed ID: 28963035
[TBL] [Abstract][Full Text] [Related]
39. B-raf and Ha-ras mutations in chemically induced mouse liver tumors.
Jaworski M; Buchmann A; Bauer P; Riess O; Schwarz M
Oncogene; 2005 Feb; 24(7):1290-5. PubMed ID: 15592514
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine.
Takizawa T; Imai T; Onose J; Ueda M; Tamura T; Mitsumori K; Izumi K; Hirose M
Toxicol Sci; 2004 Sep; 81(1):43-9. PubMed ID: 15201437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
